跳至主要内容
临床试验/IRCT20181022041406N4
IRCT20181022041406N4招募中3 期

Rivaroxaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction: A Randomized Controlled Pilot Trial

Rajaie cardiovascular medical and research center0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • All patients with the age of 18-80 admitted with an acute STEMI
  • Presence of LV thrombosis, which were confirmed by transthrocic echocardiography
  • Signed informed consent

排除标准

  • Previous history of mechanical prosthetic heart valve
  • Candidate for coronary artery bypass graft surgery
  • Active bleeding
  • Cardiogenic shock
  • Acute Kidney Injury or Chronic Kidney Disease with a glomerular filtration rate <30 ml/min
  • Liver failure (Child-Pugh class C)
  • Sensitivity or intolerance to rivaroxaban/warfarin/P2Y12 inhibitors

研究者

发起方
Rajaie cardiovascular medical and research center

相似试验